АНДИЖОН ВИЛОЯТИДА ОИВ ИНФЕКЦИЯСИ БИЛАН ЯШОВЧИ БЕМОРЛАРДА АНТИРЕТРОВИРУС ТЕРАПИЯНИНГ УЗОҚ МУДДАТЛИ КЛИНИК САМАРАДОРЛИГИНИ БАҲОЛАШ
Keywords:
ОИВ инфекцияси, антиретровирус терапия, АРВТ, CD4 лимфоцитлари, вирус юкламасиAbstract
615 нафар беморнинг ретроспектив маълумотлари таҳлил қилинди. Икки нуқтадаги вирус юкламаси мавжуд 501 беморда самарали даволаш улуши 57,3% ни ташкил этди. Содиқ беморларда клиник-иммунологик ва вирусологик натижалар яхшироқ бўлди. Кўп омилли моделда содиқликнинг йўқлиги вирусологик самарасизлик билан энг кучли боғлиқ омил сифатида қайд этилди.
Downloads
References
1. World Health Organization. (2021). Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: Recommendations for a public health approach. WHO. https://www.who.int/publications/i/item/9789240031593
2. UNAIDS. (2024). The urgency of now: AIDS at a crossroads. 2024 Global AIDS Update. https://www.unaids.org/en/resources/documents/2024/global-aids-update-2024
3. INSIGHT START Study Group. (2015). Initiation of antiretroviral therapy in early asymptomatic HIV infection. New England Journal of Medicine, 373, 795–807. https://doi.org/10.1056/NEJMoa1506816
4. Danel, C., et al. (2015). A trial of early antiretrovirals and isoniazid preventive therapy in Africa. New England Journal of Medicine, 373, 808–822. https://doi.org/10.1056/NEJMoa1507198
5. Cohen, M. S., et al. (2016). Antiretroviral therapy for the prevention of HIV-1 transmission. New England Journal of Medicine, 375, 830–839. https://doi.org/10.1056/NEJMoa1600693
6. World Health Organization. (2017). HIV drug resistance report 2017. WHO. https://www.who.int/publications/i/item/9789241512831
7. World Health Organization. (2025). WHO guideline on HIV service delivery: Updated guidance on integration and adherence. https://www.who.int/publications/i/item/9789240113879
8. World Health Organization. (2025). WHO updated recommendations on HIV clinical management: Recommendations for a public health approach. https://www.who.int/publications/i/item/9789240119468
9. Panel on Antiretroviral Guidelines for Adults and Adolescents. (2025). Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. ClinicalInfo, NIH. https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-arv
10. von Elm, E., et al. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. PLoS Medicine, 4(10), e296. https://doi.org/10.1371/journal.pmed.0040296
